Gonadal function and pubertal development in girls with classic galactosemia

Gonadic Function and Pubertal Development in Female Patients With Classic Galactosemia

IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07461519

This project will collect clinical, hormone, growth, and fertility information on girls and young women with classic galactosemia to see if specific factors are linked to ovarian insufficiency and pubertal outcomes.

Quick facts

Study typeObservational
Enrollment60 (estimated)
AgesN/A to 45 Years
SexFemale
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna (other)
Locations19 sites (Bologna, Italy and 18 other locations)
Trial IDNCT07461519 on ClinicalTrials.gov

What this trial studies

This is a large multicenter Italian observational cohort of genetically confirmed female patients with classic galactosemia, aiming to document clinical, auxological, hormonal, developmental, and fertility-related features across key pubertal stages. Data will be compared with general population references and analyzed to identify factors associated with primary ovarian insufficiency (POI). The study includes standardized clinical visits and retrospective and prospective data collection from participating Pediatric Endocrinology and Metabolic Disease centers. Secondary outcomes include final height relative to familial targets, quality of life, psycho-emotional adjustment, and cognitive/psychomotor development.

Who should consider this trial

Good fit: Female patients born between January 1, 1980 and December 31, 2024 with genetically confirmed classic galactosemia who are followed at participating Pediatric Endocrinology or Inherited Metabolic Disease centers and can provide informed consent.

Not a fit: Patients with known chromosomal abnormalities, ovarian insufficiency from other causes, males, or those without genetic confirmation of classic galactosemia are unlikely to benefit from the study's specific findings.

Why it matters

Potential benefit: If successful, the study could identify predictors of ovarian insufficiency and inform timing and options for fertility preservation and reproductive counseling for affected women.

How similar studies have performed: Previous smaller single-center reports and case series have repeatedly shown high rates of ovarian dysfunction in classic galactosemia, but large homogeneous multicenter cohorts addressing risk factors and fertility features have been lacking.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female patients followed at participating Pediatric Endocrinology and Inherited Metabolic Disease Centers, born between January 1st, 1980 and December 31st, 2024, with a diagnosis of classic galactosemia and confirmed by genetic testing.
* Obtaining informed consent.

Exclusion Criteria:

* Patients with known chromosomal abnormalities (e.g., trisomy 21, Turner syndrome, Fragile X syndrome, Kabuki syndrome, or other genetic conditions associated with pubertal disorders);
* Patients with primary ovarian insufficiency due to causes other than galactosemia.

Where this trial is running

Bologna, Italy and 18 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Galactosemia, galactosemia

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.